Sapporo Clinical Laboratory

9776.T

Key numbers · FY ended 2025-03

Revenue¥20.1bn+2.3% YoY Operating income¥706m+32.1% YoY Net income (owners)¥464m+22.1% YoY Total assets¥16.5bn-1.4% YoY EPS (basic)¥148.35+30.0% YoY

Full financial history and reports →

Stock price9776 · View chart ↗

Open the price chart on TradingView.

Latest filings

Wed, Feb 18 · JST1 filing

15:425% STAKESapporo Clinical Laboratory · Epic Partners Investments Co., Ltd. · 8.45% → 9.47%+1.02pp

Tue, Jan 27 · JST1 filing

16:045% STAKESapporo Clinical Laboratory · Epic Partners Investments Co., Ltd. · 7.13% → 8.45%+1.32pp

Wed, Jan 21 · JST1 filing

16:035% STAKESapporo Clinical Laboratory · Epic Partners Investments Co., Ltd. · 6.06% → 7.13%+1.07pp

Thu, Dec 25 · JST1 filing

15:435% STAKESapporo Clinical Laboratory · Epic Partners Investments Co., Ltd. · 5.05% → 6.06%+1.01pp

Mon, Dec 15 · JST1 filing

15:365% STAKESapporo Clinical Laboratory · Epic Partners Investments Co., Ltd. · 5.05%new 5.05%

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
dateasettomanejimennto	28.13%	—	2025-11-14
Epic Partners Investments Co., Ltd.	9.47%	+1.02pp	2026-02-18

Each holder's own ratio from its most recent large-shareholding report.